Cadence Minerals
Plc
("Cadence Minerals",
"Cadence", or "the Company")
Corporate Update
- Evergreen Lithium (ASX: EG1) Uncovers Additional
Large Pegmatite
Targets in Central-West Bynoe
Cadence Minerals (AIM: KDNC; OTC:
KDNCY) is pleased to note that ASX listed Evergreen Lithium Limited
("Evergreen") (ASX: EG1) has announced that it has received
subsequent assays from its Phase 3 geochemical soil sampling at
Bynoe in the Northern Territory, identifying additional large
lithium targets. These new targets are in the central area of the
tenement further demonstrating the potential for additional lithium
spodumene mineralisation in the Bynoe pegmatite field, and within
EverGreen's 231 square Kilometers of tenure.
Highlights:
· EverGreen's Phase 3 Geochemical sampling continues to yield
additional large geochemical anomalies at Central Bynoe.
· Assay
results from 1,214 samples received reflect similar large-scale
lithium trends to those previously identified.
· 3
large new lithium pegmatite prospects have been
identified.
· Assays
for a further 900 samples are expected to be received
shortly.
· Planned work programs for 2024 (dry season) include auger,
RAB/AC and RC drilling testing geochemical and geophysical
anomalies with potential follow-up diamond drilling.
Exploration at Evergreen's Bynoe
Project has focused on the discovery of economic lithium
mineralisation hosted in lithium-bearing lithium-cesium-tantalum
(LCT) pegmatites.
Link
here to view the full Evergreen
ASX announcement
Evergreen Exploration Manager Andrew Harwood
commented: ""These soil results add to
the potential of EverGreen identifying an economic LCT pegmatite
discovery at the company's Bynoe Project. Using a variety of proven
exploration tools, the team is looking forward to the upcoming dry
season to recommence field activities targeting the anomalies
outlined by the soils program, the ANT geophysical work, and recent
field mapping."
Background to Cadence's investment in Evergreen
Lithium
Cadence Minerals received
approximately 15.8 million shares in Evergreen in July
2022 when Cadence sold its 31.5% stake in Lithium Technologies and
Lithium Supplies ("LT and LS") to Evergreen as announced on 27 June
2022. A further AS$ 3.47 million (£1.86 million)
of shares in Evergreen are due to Cadence on the achievement of
certain performance milestones by Evergreen. The pricing of
Evergreen shares associated with this consideration is based on a
defined pricing mechanism linked to the VWAP and the date at which
the performance milestones are achieved. Further details of these
milestones can be found in the Evergreen prospectus
available here .
Cadence's shares are subject to a 2-year escrow agreement as
determined by the listing rules of the ASX.
For further information
contact:
|
|
Cadence Minerals plc
|
+44
(0) 20 3582 6636
|
Andrew Suckling
|
|
Kiran Morzaria
|
|
|
|
WH
Ireland Limited (NOMAD & Broker)
|
+44
(0) 20 7220 1666
|
James Joyce
|
|
Darshan Patel
|
|
|
|
Fortified Securities - Joint Broker
|
+44
(0) 20 3411 7773
|
Guy Wheatley
|
|
|
|
Brand Communications
|
+44
(0) 7976 431608
|
Public & Investor
Relations
|
|
Alan Green
|
|
Qualified Person
Kiran Morzaria B.Eng. (ACSM), MBA,
has reviewed and approved the information contained in this
announcement. Kiran holds a Bachelor of Engineering (Industrial
Geology) from the Camborne School of Mines and an MBA (Finance)
from CASS Business School.
Cautionary and
Forward-Looking Statements
Certain statements in this
announcement are or may be deemed to be forward-looking statements.
Forward-looking statements are identified by their use of terms and
phrases such as "believe", "could", "should", "envisage",
"estimate", "intend", "may", "plan", "will", or the negative of
those variations or comparable expressions
including references to assumptions. These forward-looking
statements are not based on historical facts but rather on the
Directors' current expectations and assumptions regarding the
company's future growth results of operations
performance, future
capital, and other expenditures (including the
amount, nature, and sources of funding thereof) competitive
advantages business prospects and opportunities. Such
forward-looking statements reflect the Directors' current beliefs
and assumptions and are based on information currently available to
the Directors. Many factors could cause actual results to
differ materially from the results discussed in the forward-looking
statements, including risks associated with vulnerability to
general economic and business conditions, competition,
environmental and other regulatory changes actions by governmental
authorities, the availability of capital markets reliance on key
personnel uninsured and underinsured losses and other factors many
of which are beyond the control of the company. Although any
forward-looking statements contained in this announcement are based
upon what the Directors believe to be reasonable assumptions. The
company cannot assure investors that actual results will be
consistent with such forward-looking statements.
The information contained within this announcement is deemed
by the company to constitute Inside Information as stipulated under
the Market Abuse Regulation (E.U.) No. 596/2014, as it forms part
of U.K. domestic law under the European Union (Withdrawal) Act
2018, as amended. Upon the publication of this announcement via a
regulatory information service, this information is considered to
be in the public domain.